G
Giovanni Barosi
Researcher at University of Pavia
Publications - 352
Citations - 21433
Giovanni Barosi is an academic researcher from University of Pavia. The author has contributed to research in topics: Myelofibrosis & Essential thrombocythemia. The author has an hindex of 69, co-authored 334 publications receiving 19225 citations.
Papers
More filters
Journal ArticleDOI
New Markers of Disease Progression in Myelofibrosis.
TL;DR: In this article, a review summarizes basic concepts of primary myelofibrosis pathogenesis, clinics, and therapy, focusing on classical prognostic scoring systems and new biological markers of the disease.
Journal Article
Evidence for the existence of two populations of erythroid cells in a case of congenital dyserythropoietic anaemia type II.
Journal Article
The use of 59Fe for estimating red cell production and destruction: a comparative evaluation of two methods for the analysis of experimental data.
Mario Cazzola,P. Alessandrino,Giovanni Barosi,Carlo Berzuini,Francesco Frassoni,Ester Orlandi,Mario Stefanelli,Silvio Perugini +7 more
Journal ArticleDOI
Clinical Evolution to Primary Myelofibrosis - Blast Phase: An International Working Group for Myelofibrosis Research and Treatment (IWG-MRT) Collaborative Retrospective Analysis.
Ruben A. Mesa,Francisco Cervantes,Srdan Verstovsek,Constantine S. Tam,Brigitte Dupriez,John T. Reilly,Giovanni Barosi,Megan E. Campbell,Wenting Wu,Animesh Pardanani,Terra L. Lasho,Ayalew Tefferi +11 more
TL;DR: Analyzing the clinical evolution between groups demonstrated persistently higher LDH and worsening thrombocytopenia in the PMF-BP cohort, and clonal evolution are features commonly seen in PMF patients whom evolve to blast phase and may be a harbinger of movement towards PMF BP.
Journal ArticleDOI
Management of infectious risk of daratumumab therapy in multiple myeloma: a consensus-based position paper from an ad hoc Italian expert panel.
Corrado Girmenia,Michele Cavo,Alessandro Corso,Francesco Di Raimondo,Pellegrino Musto,Massimo Offidani,Maria Teresa Petrucci,Antonio Rosato,Giovanni Barosi +8 more
TL;DR: In this article , an expert panel convened to compose recommendations for optimal infection control in patient candidates to or under daratumumab treatment for multiple myeloma (MM) patients.